

Guardant Health (NASDAQ:GH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Guardant Health (NASDAQ:GH) through any online brokerage.
Other companies in Guardant Health’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and BrightSpring Health Services Inc (NASDAQ:BTSG).
Guardant Health has a consensus price target of $170.07.
The stock price for Guardant Health (NASDAQ: GH) is $150 last updated November 6, 2026 at 5:23 PM EST.
There are no upcoming dividends for Guardant Health.
Guardant Health does not have any upcoming earnings scheduled.
There is no upcoming split for Guardant Health.
Guardant Health is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing,...